+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Type-3 serotonin receptor blockaders (5-HT3)--a new class of antiemetic preparations



Type-3 serotonin receptor blockaders (5-HT3)--a new class of antiemetic preparations



Eksperimental'naia i Klinicheskaia Farmakologiia 57(4): 72-75




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047860252

Download citation: RISBibTeXText

PMID: 7950795


Related references

Third type serotonin receptor blockers (5-HT-3) as a new class of antiemetic drugs. Eksperimental'naya i Klinicheskaya Farmakologiya 57(4): 72-75, 1994

Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen. American Journal of Clinical Oncology 16(2): 175-179, 1993

Effect of ginseng saponins on the recombinant serotonin type 3A receptor expressed in xenopus oocytes: implication of possible application as an antiemetic. Journal of Alternative and Complementary Medicine 9(4): 505-510, 2003

New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature). Farmakologiia i Toksikologiia 41(5): 624-632, 1978

Serotonin antagonists: a new class of antiemetic agents. Journal of the National Cancer Institute 83(9): 613-620, 1991

Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva). European Journal of Pharmacology 722: 2-12, 2014

Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases. Klinicheskaia Meditsina 69(3): 27-34, 1991

Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases. Klinicheskaia Meditsina 69(3): 23-27, 1991

Antiemetic effects of ad 5370 a novel serotonin 5 ht 3 receptor antagonists. European Journal of Pharmacology 183(4): 1214-1215, 1990

Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new antiemetic in oncology. Bulletin du Cancer 78(12): 1139-1146, 1991

The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications. Drugs 53(1): 20-39, 1997

Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents. Medicinal Research Reviews 19(1): 25-73, 1999

Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs. Japanese Journal of Pharmacology 57(3): 387-395, 1991

Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy. Gynecologic Oncology 85(3): 435-437, June, 2002